A. Reduce incidence of respiratory illness
B. Reduce decline in FEV1 over time
C. Reduce airway hyperreactivity
D. Do not counteract the effects of smoking
E. May lead to reduced bone density
A. Autoimmune Hemolytic Anemia
B. Hypogammaglobulinemia
C. Atypical Mycobacterial Infection
D. Disease Transformation to leukemia or lymphoma
E. Increased risk of unrelated cancers
A. Associated with increased risk of hemorrhagic stroke in men but not women
B. Causes marked increases in blood pressure in patients with borderline hypertension
C. Blocks both histamine H1 and H2 receptor types
D. Has been withdrawn from over-the-counter medications for both obesity and cold symptoms
E. Causes vasodilation of nasal and other blood vessels
A. ß-Adrenergic Agonists
B. Myocardial Infarction - particularly inferior MI
C. Anti-Ro and/or Anti-La autoantibodies
D. Digoxin
E. Calcium Channel Blockers
A. Octreotide (a somatostatin analog, Sandostatin®) given intravenously reduces rebleeding by ~90% combined with endoscopic ligation alone
B. Another somatostatin analog, vapreotide, reduces rebleeding by >60%
C. Somatostatin and its analogs may reduce need for blood transfusion
D. Natural somatostatin combined with sclerotherapy reduced acute bleeding episodes []
E. Somatostatin and its analogs have been shown to reduce mortality associated with variceal bleeding
A. Mast Cell
B. Eosinophil
C. Neutrophil
D. Type 2 T helper Lymphocyte
E. B Lymphocyte
A. PTCA is very effective for treatment of single-vessel coronary artery disease (CAD)
B. Coronary artery bypass grafting (CABG) is typically preferred over PTCA for multivessel CAD
C. PTCA without stenting is associated with ~30% incidence of restenosis within 2 years
D. PTCA is effective in graft revascularization following CABG
E. PTCA is associated with less post-procedure angina and less emergent CABG than medical therapy alone
A. Initial debridement
B. Leg elevation
C. Compression therapy
D. Surgery for superficial valvular incompetence
E. Pentoxifylline
A. Angiography is the gold standard for the diagnosis
B. Duplex ultrasonography is relatively inexpensive and reasonably accurate for diagnosis
C. Ankle-brachial blood pressure comparisons (A-B index) is a reasonable screening tool
D. Renal function need not be evaluated in most patients with peripheral arterial disease
E. Magnetic resonance angiography (MRA) is a modality of choice for initial diagnosis
A. Physical examination is adequate to screen patients with possible AAA
B. Initial ultrasound in all men >65 years of age reduces risk of AAA rupture by nearly 50%
C. Aneurysms >5.5cm should be followed up with ultrasound examination every 6 months
D. Physical examination has a higher positive predictive value for AAA in obese patients than in non-obese patients
E. Physical examination will detect >95% of AAA of width >5.4cm
| TOPIC CARD REFERENCES |